Korea South
Medipixel, founded in 2017, is a pioneering MedTech startup headquartered in Korea South that leverages AI to enhance diagnostic and therapeutic procedures in coronary interventions. With a mission embodied in its slogan, "AI solutions for diagnostic and therapeutic procedures in coronary interventions," the company addresses critical healthcare challenges through its innovative solutions.
Comprising a team of AI specialists in computer vision, deep learning, and reinforcement learning, Medipixel collaborates with top-tier medical institutions such as the Seoul Asan Medical Center. Their offerings include an AI Based Diagnosis Solution that facilitates lesion detection during angiography, a Guide & Planning Solution that visualizes coronary arteries and omits the need for contrast, and an Automated Navigation Engine that automates coronary navigation and device delivery.
Attracting significant investor interest, Medipixel recently secured a substantial KRW17.00B Series B investment on 26 October 2023 from prominent investors including Company K Partners, Premier Partners, DAYLI Partners, IMM Investment, Industrial Bank of Korea, Quad Asset Management, and SBI Investment Korea.
